Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences Statistics

Total Valuation

CRBU has a market cap or net worth of $76.09 million. The enterprise value is -$110.14 million.

Market Cap	76.09M
Enterprise Value	-110.14M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CRBU has 93.00 million shares outstanding. The number of shares has increased by 12.77% in one year.

Current Share Class	93.00M
Shares Outstanding	93.00M
Shares Change (YoY)	+12.77%
Shares Change (QoQ)	+1.67%
Owned by Insiders (%)	4.70%
Owned by Institutions (%)	61.30%
Float	83.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.52
Forward PS	7.46
PB Ratio	0.35
P/TBV Ratio	0.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.63, with a Debt / Equity ratio of 0.12.

Current Ratio	7.63
Quick Ratio	7.41
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.76% and return on invested capital (ROIC) is -32.38%.

Return on Equity (ROE)	-52.76%
Return on Assets (ROA)	-29.21%
Return on Invested Capital (ROIC)	-32.38%
Return on Capital Employed (ROCE)	-64.87%
Revenue Per Employee	$67,469
Profits Per Employee	-$1.01M
Employee Count	147
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	-9,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.89% in the last 52 weeks. The beta is 2.36, so CRBU's price volatility has been higher than the market average.

Beta (5Y)	2.36
52-Week Price Change	-76.89%
50-Day Moving Average	0.90
200-Day Moving Average	1.63
Relative Strength Index (RSI)	48.00
Average Volume (20 Days)	1,046,475

Short Selling Information

The latest short interest is 7.63 million, so 8.21% of the outstanding shares have been sold short.

Short Interest	7.63M
Short Previous Month	9.48M
Short % of Shares Out	8.21%
Short % of Float	9.09%
Short Ratio (days to cover)	8.83

Income Statement

In the last 12 months, CRBU had revenue of $9.92 million and -$147.86 million in losses. Loss per share was -$1.62.

Revenue	9.92M
Gross Profit	-119.76M
Operating Income	-159.03M
Pretax Income	-123.25M
Net Income	-147.86M
EBITDA	-154.65M
EBIT	-159.03M
Loss Per Share	-$1.62

Balance Sheet

The company has $208.47 million in cash and $26.22 million in debt, giving a net cash position of $186.23 million or $2.00 per share.

Cash & Cash Equivalents	208.47M
Total Debt	26.22M
Net Cash	186.23M
Net Cash Per Share	$2.00
Equity (Book Value)	217.22M
Book Value Per Share	2.34
Working Capital	188.83M

Cash Flow

In the last 12 months, operating cash flow was -$137.72 million and capital expenditures -$4.47 million, giving a free cash flow of -$142.20 million.

Operating Cash Flow	-137.72M
Capital Expenditures	-4.47M
Free Cash Flow	-142.20M
FCF Per Share	-$1.53

Margins

Gross Margin	n/a
Operating Margin	-1,603.42%
Pretax Margin	-1,490.94%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRBU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.77%
Shareholder Yield	-12.77%
Earnings Yield	-194.33%
FCF Yield	-186.89%

Analyst Forecast

The average price target for CRBU is $10.60, which is 1,195.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.60
Price Target Difference	1,195.69%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	172.29%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CRBU has an Altman Z-Score of -1.49 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.49
Piotroski F-Score	1